Get Q3 2025 Pfizer earnings call insights—guidance raised, major acquisitions, regulatory updates, and R&D highlights.

Good day, everyone, and welcome to Pfizer's Third Quarter 2025 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Francesca DeMartino, Chief ...

In these uncertain, volatile, and unprecedented times, the role of science is more important than ever. Scientific advances that benefit humanity and ensure planetary sustainability for current and ...

Once upon a time, not so long ago, an industrial developer in Texas could pick an appropriately zoned spot on the map, throw ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

This is proving to be the direction digitalization is heading. A study this year by Deloitte found that three-quarters (75%) of companies plan to increase their smart manufacturing budgets, with ...

President Donald Trump has received updated flu and COVID-19 booster shots in preparation for upcoming travel, the president’s physician announced Oct. 10. Sean P. Barbabella, a U.S. Navy captain, ...

For those working in global health, and especially on immunisation, it is difficult not to feel despair at the headwinds in ...

Ratutrelvir, a ritonavir-free Main protease (Mpro/3CL) inhibitor, was discovered and developed ab initio from target to clinic by ChemDiv's medicinal chemistry and virology services teams. Leveraging ...

Tettey, Acting Chief Executive Officer of the National Vaccine Institute (NVI), has emphasised the critical need ...

Novavax, Inc. (NASDAQ:NVAX) is one of the top long-term biotechnology stocks to buy. On October 24, Cantor Fitzgerald ...

President Trump’s second term has been marked by a flurry of company pledges to expand production in the United States. From ...